Company profile: PHT
1.1 - Company Overview
Company description
- Provider of Web-based clinical trial direct data capture and management technologies, including market-leading electronic patient reported outcome (ePRO) solutions used globally in clinical trials. Offers LogPad and StudyPad systems to improve data quality and the StudyWorks online portal providing study sponsors, monitors and sites with real-time access.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PHT
eMolecules
HQ: United States
Website
- Description: Provider of a free chemical structure search engine to search and order over 50M unique structures and 76M part numbers, including 4.5M building blocks and 20.3M screening compounds from 210+ suppliers. Offers compound reformatting, inventory management and global distribution, a virtual chemical space of over 4.9 trillion compounds for drug discovery, and structure data downloads for virtual screening, lead optimization, and cheminformatics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eMolecules company profile →
Frontier Medicines
HQ: United States
Website
- Description: Provider of a biopharmaceutical drug discovery platform integrating chemoproteomics, covalent chemistry, and machine learning to accelerate medicine development; programs include a dual KRASG12C inhibitor (FMC-376) targeting active and inactive forms in cancers and AutoTAC for autophagy-driven targeted degradation; tools span ML/AI prioritization, chemoproteomics to identify druggable hotspots, and a covalent fragment library.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frontier Medicines company profile →
Parabricks
HQ: United States
Website
- Description: Provider of high-performance genomic analysis that can analyze a whole human genome in under an hour, compared to days, using state-of-the-art GPU acceleration and machine learning. Enables users to significantly increase throughput and supports personalized treatment based on genomic variations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parabricks company profile →
Clinical Ink
HQ: United States
Website
- Description: Provider of eSource solutions for the clinical trials industry, offering software to record validated source data, comments, and explanations on protocol-specific electronic documents via mobile devices, including its SureSource electronic source solution that captures data required by trial protocols.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Ink company profile →
Allcyte
HQ: Austria
Website
- Description: Provider of functional drug testing in primary human material using the Pharmacoscopy high-content imaging platform and AI-supported image analysis pipelines to advance precision and personalized medicine for cancer patients and treating physicians, while supporting pharmaceutical companies in drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allcyte company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PHT
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PHT
2.2 - Growth funds investing in similar companies to PHT
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PHT
4.2 - Public trading comparable groups for PHT
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →